Exp Mol Med.  2002 Nov;34(5):319-325.

Prevention of liver cancer: basic and clinical aspects

Affiliations
  • 1Department of Internal Medicine, Gifu University School of Medicine, Gifu, Japan. hmori@cc.gifu-u.ac.jp

Abstract

Cancer prevention is a challenging project both in the basic and clinical medicine. In particular, prevention of liver cancer is the most urgent task in countries where the incidence of hepatitis virus-related liver cancer is rising. As reviewed in this article, liver cancer is going to be the first cancer that will be actually prevented by primary and secondary interventions. Even the improvement of absolute survival of the patients can be expected by successful prevention, as already demonstrated in a few clinical trials. Thus, prevention of liver cancer is promising to provide not only cost-effectiveness by morbidity reduction but also cost-benefit by mortality improvement.

Keyword

AFP, alpha-fetoprotein; HBV, hepatitis B virus; HCV, hepatitis C virus; RXR, retinoid X receptor

MeSH Terms

Animals
Chemoprevention
Hepatitis B/complications/drug therapy
Human
Liver Neoplasms/etiology/*prevention & control
Retinoids/*therapeutic use
Full Text Links
  • EMM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr